Skip to content
Clinical Trials – home
Research siteResponsive

Revmacentrum MUDr. Mostera s.r.o.

Czechia Mosnova 2476/8, Zidenice, 615 00 Brno-Zidenice, Czechia

  • 2 trials recruiting
  • Psoriatic arthropathy · Axial spondyloarthritis · Ankylosing spondylitis
  • Adults and children

About Specializations

Revmacentrum MUDr. Mostera s.r.o. in Brno-Zidenice, Czechia specialises in clinical trials of conditions such as Psoriatic arthropathy, Axial spondyloarthritis, Ankylosing spondylitis, Juvenile idiopathic arthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

Revmacentrum MUDr. Mostera s.r.o. conducts research on immune‑mediated conditions, evaluating new therapies for psoriatic arthritis, rheumatoid arthritis, and related inflammatory disorders.

  • Psoriatic arthritis treatment effectiveness
  • Rheumatoid arthritis therapeutic assessment
  • Giant cell arteritis and polymyalgia rheumatica investigations

The site’s focus on immune health aims to improve patient outcomes by testing innovative biologic agents and safety profiles.

Musculoskeletal Diseases

Clinical studies at the Brno‑Zidenice facility explore joint and bone disorders, including osteoarthritis and knee structural changes, to enhance treatment options for patients with chronic musculoskeletal pain.

  • Knee osteoarthritis structural and symptomatic evaluation
  • Osteoarthritis disease‑modifying therapy research
  • Assessment of novel agents for joint health

By investigating disease progression and therapeutic impact, the centre seeks to advance care for individuals with musculoskeletal ailments.

Skin and Connective Tissue Diseases

The research program includes studies on conditions that affect skin and connective tissues, particularly psoriatic arthritis and related psoriasis‑driven joint disease, to refine diagnostic tools and therapeutic strategies.

  • Psoriasis‑associated arthritis clinical evaluation
  • Connective tissue disease treatment innovation
  • Safety and efficacy of emerging biologics

Efforts at Revmacentrum aim to translate scientific insights into better management of skin‑related inflammatory disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Mosnova 2476/8, Zidenice615 00 Brno-ZideniceCzechia
Recruiting now
2 trials
Conditions studied
7

More sites in Brno-ZideniceCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

10 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Lna043
  • Sponsor:Novartis Pharma AG

Psoriatic arthropathy

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International

Psoriatic arthropathy

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen - Cilag International
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Axial spondyloarthritis+1

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Abt-494
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.